References
- Non-Muscle Invasive Bladder Cancer: American Urological Association Available from: http://www.auanet.org/education/guidelines/non-muscle-invasive-bladder-cancer.cfmAccessed June 15, 20164
- MunozJJEllisonLMUpper tract urothelial neoplasms: incidence and survival during the last 2 decadesJ Urol200016451523152511025695
- FangDLiX-SXiongG-YYaoLHeZ-SZhouL-QProphylactic intravesical chemotherapy to prevent bladder tumors after nephroureterectomy for primary upper urinary tract urothelial carcinomas: a systematic review and meta-analysisUrol Int201391329129623948770
- MargulisVShariatSFMatinSFUpper Tract Urothelial Carcinoma CollaborationThe Upper Tract Urothelial Carcinoma CollaborationOutcomes of radical nephroureterectomy: a series from the upper tract urothelial carcinoma collaborationCancer200911561224123319156917
- RouprêtMBabjukMCompératEEuropean association of urology guidelines on upper urinary tract urothelial carcinoma: 2017 updateEur Urol201873111112228867446
- LeblancBDuclosAJBénardFLong-term followup of initial Ta grade 1 transitional cell carcinoma of the bladderJ Urol199916261946195010569544
- ZigeunerREHuttererGChromeckiTRehakPLangnerCBladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour locationBJU Int20069861181118617125475
- NovaraGDe MarcoVDalpiazOIndependent predictors of metachronous bladder transitional cell carcinoma (TCC) after nephroureterectomy for TCC of the upper urinary tractBJU Int2008101111368137418241252
- XylinasERinkMMargulisVKarakiewiczPNovaraGShariatSFMultifocal carcinoma In situ of the upper tract is associated with high risk of bladder cancer recurrenceEur Urol20126151069107022402109
- MilláN-RodríGuezFChéChile-TonioloGSalvador-BayarriJHuguet-PéRezJVicente-RodríGuezJUpper urinary tract tumors after primary superficial bladder tumors: prognostic factors and risk groupsJ Urol200016441183118710992362
- HabuchiTMetachronous multifocal development of urothelial cancers by intraluminal seedingLancet19933428879108710888105314
- CattoJWFHartmannAStoehrRMultifocal urothelial cancers with the mutator phenotype are of monoclonal origin and require panurothelial treatment for tumor clearanceJ Urol200617562323233016697867
- HafnerCKnuechelRZanardoLEvidence for oligoclonality and tumor spread by intraluminal seeding in multifocal urothelial carcinomas of the upper and lower urinary tractOncogene2001203549104915 Available from: http://search.ebscohost.com/login.aspx?direct=true&profile=ehost&scope=site&authtype=crawler&jrnl=09509232&AN=8911021&h=ILJ1sWCVqqV3Sw9NbreemxkktylKW8OoniW5BwJrYkI35JgFThDZWj9lfXwnGF92ye%2FpdtM1QGUYG35RAfk94w%3D%3D&crl=cAccessed November 4, 201611521204
- TakahashiTKakehiYMitsumoriKDistinct microsatellite alterations in upper urinary tract tumors and subsequent bladder tumorsJ Urol2001165267267711176456
- BadalamentRAHerrHWWongGYA prospective randomized trial of maintenance versus nonmaintenance intravesical bacillus Calmette-Guérin therapy of superficial bladder cancerJ Clin Oncol1987534414493546618
- SylvesterRJOosterlinckWWitjesJAThe schedule and duration of intravesical chemotherapy in patients with non–muscle-invasive bladder cancer: a systematic review of the published results of randomized clinical trialsEur Urol200853470971918207317
- SobinLHGospodarowiczMKWittekindCTNM Classification of Malignant Tumours7th revised edHoboken, USAJohn Wiley & Sons2009
- Lopez-BeltranAGasserTHartmannATumours of the urinary systemEbleJNSauterGEpsteinJISesterhennIAWorld Health OrganisationClassification of Tumors Pathology and Genetics of Tumours of the Urinary System and Male Genital OrgansLyon, FranceIARC Press200488157
- Professionals S-OUpper Urinary Tract Urothelial Cell CarcinomaUroweb Available from: https://uroweb.org/guideline/upper-urinary-tract-urothelial-cell-carcinoma/?type=summary-of-changesAccessed June 15, 2016
- SeisenTGrangerBColinPA systematic review and meta-analysis of clinicopathologic factors linked to intravesical recurrence after radical nephroureterectomy to treat upper tract urothelial carcinomaEur Urol20156761122113325488681
- SylvesterRJvan der MeijdenAPMOosterlinckWPredicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trialsEur Urol200649346647716442208
- O’BrienTRayESinghRCokerBBeardRBritish Association of Urological Surgeons Section of OncologyPrevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial)Eur Urol201160703–10 Eur Urol2012613e1421684068
- WuW-JKeH-LYangY-HLiC-CChouY-HHuangC-HShould patients with primary upper urinary tract cancer receive prophylactic intravesical chemotherapy after nephroureterectomy?J Urol20101831566119913833
- ItoAShintakuISatohMProspective randomized Phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP monotherapy study group trialJ Clin Oncol201331111422142723460707
- WuPZhuGWeiDProphylactic intravesical chemotherapy decreases bladder tumor recurrence after nephroureterectomy for primary upper tract urothelial carcinoma: a systematic review and meta-analysisJ BUON20152051229123826537069